Latest
Benefits of Title III Equity Crowdfunding to Entrepreneurs

Benefits of Title III Equity Crowdfunding to Entrepreneurs

In May 2016, Title III of the JOBS Act will open the equity markets further to non-accredited investors and significantly grow the pool of…
Go to the profile of Wemultiply
Wemultiply3 days ago
The Disruption of Early Stage Funding Models

The Disruption of Early Stage Funding Models

Prior to the implementation of the Securities Acts of 1933 and 1934, capital markets in the US were effectively governed by the ‘law of the…
Go to the profile of Wemultiply
WemultiplyApr 4
Will Equity Crowdfunding Overtake Angel and VC?

Will Equity Crowdfunding Overtake Angel and VC?

The World Bank estimates that the total value of yearly crowdfunding deals could reach $90 billion by 2020. To put that into perspective…
Go to the profile of Wemultiply
WemultiplyApr 4
The Mob Rushes In: Disruptive Funding Models for Early Stage Businesses (Webinar)

The Mob Rushes In: Disruptive Funding Models for Early Stage Businesses (Webinar)

Prior to the implementation of the Securities Acts of 1933 and 1934, capital markets in the US were effectively governed by the ‘law of the…
Go to the profile of Wemultiply
WemultiplyMar 22
Latest
Series A Not Dead — But Investor and Partner Networks Are Key To Survival

Series A Not Dead — But Investor and Partner Networks Are Key To Survival

The Accelerator Group’s Robin Klein posted a piece on early-stage investments entitled “$1b has ‘gone’ in 4 Years: Should tech angels stop…
Go to the profile of Wemultiply
WemultiplyFeb 26
Can Artificial Intelligence Productively Impact the Patient Journey?

Can Artificial Intelligence Productively Impact the Patient Journey?

A recent article in The New York Times highlights the ongoing advancements being made in artificial intelligence (AI), focusing primarily…
Go to the profile of Wemultiply
WemultiplyFeb 19
Is 23andMe back on track?

Is 23andMe back on track?

23andMe is on the path to bridging the gap between genomics and pharmaceutical companies given the new business track and structuring…
Go to the profile of Wemultiply
WemultiplyFeb 19
The Technological Footprint of the PPACA

The Technological Footprint of the PPACA

While the rest of America is focusing on increased insurance premiums, here at weMultiply we’ve been looking at the technological impact…
Go to the profile of Wemultiply
WemultiplyFeb 19

PPACA Today: New Year, New Rules

January 1, 2014 marked more than just a new year for a new you; it’s a new year with new rules from the Patient Protection Affordable Care…
Go to the profile of Wemultiply
WemultiplyFeb 19
About
The Wemultiply Digest
The Wemultiply Digest

Wemultiply exists to improve outcomes and prolong lives by connecting healthtech companies with capital partners ready to drive rapid growth. Through our work at the forefront of digital health, we publish insights on the trends shaping the future of healthtech investing.

More information

Followers
Elsewhere
More stories →About The Wemultiply Digest